Deuxième analyse intermédiaire d’une étude en ouvert du Leniolisib dans le syndrome PI3Kδ activée : efficacité et tolérance long terme
Year: 2024
Type: article
Source: La Revue de Médecine Interne
Authors: V.K. Rao, A. Sediva, V. Dalm, P. Alessandro, S. Catharina, A. Shcherbina, A. Trizzino, E. Kulm, Y. Zharankova, J. Körholz, V. Lougaris, J. Rodina, J. Bradt, S. Webster, O. Alanvin, D. Vandier, X. Amores, A. Relan, U. Gulbu
Institutions: National Institutes of Health, National Institutes of Health Clinical Center, Charles University, Erasmus University Rotterdam, University of Brescia, University Hospital Carl Gustav Carus, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, National Institute of Allergy and Infectious Diseases, Pharming Group (Netherlands)
Language: French
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4399418407